These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12962043)

  • 1. [Development and pharmacology of nootropic and antidepressive preparations based on EAA receptor ligands].
    Petrov VI
    Eksp Klin Farmakol; 2003; 66(2):20-3. PubMed ID: 12962043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The EAA-ergic modulation of the brain dopaminergic system as a basis for creating new nootropic agents with stress-protective activity].
    Petrov VI; Grigor'ev IA
    Vestn Ross Akad Med Nauk; 1998; (11):29-34. PubMed ID: 9889702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of synaptic transmission in memory and neurodegeneration processes and effects of neurotropic preparations].
    Voronina TA
    Eksp Klin Farmakol; 2003; 66(2):10-4. PubMed ID: 12962041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential glutamatergic modulation of monoamine release in the limbic lobe by selective anticonvulsant ionotropic and metabotropic glutamate receptor ligands.
    Smolders I
    Verh K Acad Geneeskd Belg; 2005; 67(5-6):371-98. PubMed ID: 16408832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nootropes (cognition enhancers) and neuroprotectors].
    Vornin TA; Seredenin SB
    Eksp Klin Farmakol; 2007; 70(4):44-58. PubMed ID: 18078043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glutamate transporter and receptor ligands on neuronal glutamate uptake.
    Boeck CR; Kroth EH; Bronzatto MJ; Jardim FM; Souza DO; Vendite D
    Neurosci Res; 2005 Sep; 53(1):77-83. PubMed ID: 16011854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylalkyl 1,2-diamines as sigma-receptor ligands: the discovery of novel antidepressant agents.
    Kim YG; Seo SY; Heo J; Park CE; Lee EH; Choi YM
    Methods Find Exp Clin Pharmacol; 2006; 28(1):7-11. PubMed ID: 16541191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glutamate transport substrates and glutamate receptor ligands on the activity of Na-/K(+)-ATPase in brain tissue in vitro.
    Nanitsos EK; Acosta GB; Saihara Y; Stanton D; Liao LP; Shin JW; Rae C; Balcar VJ
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):762-9. PubMed ID: 15566390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
    Palucha A; Pilc A
    Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs.
    Barbon A; Popoli M; La Via L; Moraschi S; Vallini I; Tardito D; Tiraboschi E; Musazzi L; Giambelli R; Gennarelli M; Racagni G; Barlati S
    Biol Psychiatry; 2006 Apr; 59(8):713-20. PubMed ID: 16460696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modern problems of the pharmacology of nootropic agents: the status and outlook].
    Voronina TA
    Farmakol Toksikol; 1991; 54(2):6-11. PubMed ID: 1653153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxoisoaporphine Alkaloids: Prospective Anti-Alzheimer's Disease, Anticancer, and Antidepressant Agents.
    Zhang J; Chen L; Sun J
    ChemMedChem; 2018 Jul; 13(13):1262-1274. PubMed ID: 29696800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitatory amino acids in the forebrain of the Naples high-excitability rats: neurochemical and behavioural effects of subchronic D-aspartate and its diethyl ester prodrug.
    Ruocco LA; Di Pizzo A; Carnevale UA; Murolo M; Sadile AG; Arra C; Topo E; D'Aniello A; Curcio A; Melisi D; Rimoli MG
    Behav Brain Res; 2009 Mar; 198(1):37-44. PubMed ID: 19041899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs.
    Kling A; Lange UE; Mack H; Bakker MH; Drescher KU; Hornberger W; Hutchins CW; Möller A; Müller R; Schmidt M; Unger L; Wicke K; Schellhaas K; Steiner G
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5567-73. PubMed ID: 16219465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in the molecular treatment of depression].
    Páez X; Hernández L; Baptista T
    Rev Neurol; 2003 Sep 1-15; 37(5):459-70. PubMed ID: 14533097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New trends in the search for nootropic preparations].
    Voronina TA
    Vestn Ross Akad Med Nauk; 1998; (11):16-21. PubMed ID: 9889699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel isothiourea derivatives as potent neuroprotectors and cognition enhancers: synthesis, biological and physicochemical properties.
    Perlovich GL; Proshin AN; Volkova TV; Kurkov SV; Grigoriev VV; Petrova LN; Bachurin SO
    J Med Chem; 2009 Apr; 52(7):1845-52. PubMed ID: 19338354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review.
    Millan MJ
    Eur J Pharmacol; 2004 Oct; 500(1-3):371-84. PubMed ID: 15464046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of glutamate in the pathophysiology of depression.
    Palucha A; Pilc A
    Drug News Perspect; 2005 May; 18(4):262-8. PubMed ID: 16034483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nootropic agents stimulate neurogenesis. Brain Cells, Inc.: WO2007104035.
    Taupin P
    Expert Opin Ther Pat; 2009 May; 19(5):727-30. PubMed ID: 19441945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.